BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32729669)

  • 21. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
    Zhu S; Huang Y; Su X
    Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircSMC3 regulates gastric cancer tumorigenesis by targeting miR-4720-3p/TJP1 axis.
    Xia T; Pan Z; Zhang J
    Cancer Med; 2020 Jun; 9(12):4299-4309. PubMed ID: 32314520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis.
    Zhang G; Wang J; Tan W; Han X; Han B; Wang H; Xia Y; Sun Y; Li H
    Acta Histochem; 2021 Sep; 123(6):151752. PubMed ID: 34274607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
    Liu Y; Song J; Liu Y; Zhou Z; Wang X
    J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0008717 promotes renal cell carcinoma progression by upregulating FBXO17 via targeting miR-217.
    Shen S; Jiang M; Deng W; Liu X; Xiong J; Zeng Z; Zhao H; Zeng X; Fu B
    J Gene Med; 2022 Nov; 24(11):e3418. PubMed ID: 35357059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas.
    He J; Huang Z; He M; Liao J; Zhang Q; Wang S; Xie L; Ouyang L; Koeffler HP; Yin D; Liu A
    Mol Cancer; 2020 Jan; 19(1):17. PubMed ID: 31992303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
    Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
    Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy.
    Wang Y; Zhang Y; Wang P; Fu X; Lin W
    Mol Cancer; 2020 Oct; 19(1):149. PubMed ID: 33054773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
    Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
    FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis.
    Liu P; Cai S; Li N
    Exp Cell Res; 2020 Sep; 394(2):112141. PubMed ID: 32535033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0039569 Competes with MARCKS for miR-133b Binding Sites to Promote the Progression of Renal Cell Carcinoma.
    Zhao P; Zhang J
    Nephron; 2022; 146(4):404-417. PubMed ID: 35086110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
    Yamada Y; Arai T; Sugawara S; Okato A; Kato M; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2018 Apr; 109(4):1239-1253. PubMed ID: 29417701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal circular RNA_400068 promotes the development of renal cell carcinoma via the miR‑210‑5p/SOCS1 axis.
    Xiao H; Shi J
    Mol Med Rep; 2020 Dec; 22(6):4810-4820. PubMed ID: 33173957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.